HUB INTERNATIONAL ACQUIRES RETIREMENT AND PRIVATE WEALTH BOOKS OF BUSINESS IN TENNESSEE
CHICAGO, March 7, 2025 /PRNewswire/ — Hub International Limited (Hub), a leading global insurance brokerage and financial services firm, has hired financial... Read more.
Record-Breaking Ethernet Data Center Switch Sales Fueled by Robust AI Buildouts and a Recovery in Traditional Front-End Networks, According to Dell’Oro Group
Arista, Celestica, NVIDIA, and Ruijie Captured the Bulk of the Sales Increase REDWOOD CITY, Calif., March 7, 2025 /PRNewswire/ — According to a recently published... Read more.
Trumid Reports February Performance
Electronic bond trading platform announces monthly activity NEW YORK, March 7, 2025 /PRNewswire/ — Trumid, a financial technology company and leading fixed... Read more.
AMERICANS FROM ALL BACKGROUNDS WILL MAKE THE CASE FOR CIVIC EDUCATION DURING CIVIC LEARNING WEEK, MARCH 10-14, 2025
Nationwide events featuring 66th Secretary of State Condoleezza Rice, filmmaker Ken Burns, and thousands of others will highlight the power of civic education, culminating... Read more.
First HR AI Success Metrics Beyond “Saving Time” Emerge from Josh Bersin Company Analysis
Until now, CHROs have been told that AI is transformational, but without solid proof That’s finally changing, as Josh Bersin Company analysis of global SAP... Read more.
BIMZELX® (bimekizumab-bkzx) Five-Year Data at AAD 2025 Showed Sustained Skin Clearance and Long-Term Efficacy in Moderate-to-Severe Plaque Psoriasis
Sustained complete skin clearance over five years: In a subset of 153 patients from the second extension of BE BRIGHT, 67.7% of patients with moderate-to-severe... Read more.
Patient-Centric Data Capture Fuels Growth of Target RWE Longitudinal, Real-World Dermatology Studies
Insights into Hidradenitis Suppurativa from Target RWE Featured in Posters at AAD 2025 DURHAM, N.C., March 7, 2025 /PRNewswire/ — Real-world evidence (RWE)... Read more.
BIMZELX® (bimekizumab-bkzx) Two-Year Data at AAD Showed Potential to Eliminate Draining Tunnels in Hidradenitis Suppurativa, and Reduction in Disease Burden
Over half of patients had no draining tunnels (DTs) at two years: In 425 hidradenitis suppurativa (HS) patients with ≥1 DTs at baseline, 55.7% (195/350) had no... Read more.
Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering
STATEN ISLAND, N.Y., March 7, 2025 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“we” or “Acurx” or the “Company”),... Read more.
Arthur J. Gallagher & Co. Receives Second Request for Information Related to its HSR Filing for the Purchase of AssuredPartners
ROLLING MEADOWS, Ill., March 7, 2025 /PRNewswire/ — Arthur J. Gallagher & Co. (“Gallagher”) today announced it has received a request for additional... Read more.